Systematic review with meta-analysis: recurrence of hepatocellular carcinoma following direct-acting antiviral therapy.
N SaraiyaA C YoppN E RichM OdewoleNeehar D ParikhAmit G SingalPublished in: Alimentary pharmacology & therapeutics (2018)
Current data suggest acceptable HCC recurrence rates after DAA therapy, particularly if DAA therapy is delayed at least 6 months after HCC complete response. However, data characterising HCC recurrence after DAA therapy are of limited quality, highlighting the need for high quality prospective studies.